Literature DB >> 2240369

Human T cell lymphotropic virus infection in Guaymi Indians from Panama.

W C Reeves1, J R Cutler, F Gracia, J E Kaplan, L Castillo, T M Hartley, M M Brenes, M Larreategui, S Loo de Lao, C Archbold.   

Abstract

Preliminary studies found that 9% of Guaymi Indians from Bocas del Toro province have antibody to human T cell lymphotropic virus (HTLV-I/II). The present study enrolled 317 (21% of the population) Guaymi Indians from Changuinola, the capital of Bocas del Toro province and 333 (70% of the population) from Canquintu, an isolated rural village. Demographic information and family relationships were ascertained and subjects were screened for neurologic diseases. Serum specimens were screened by an enzyme-linked immunosorbent assay for HTLV-I/II antibody and positives were confirmed according to U.S. Public Health Service criteria. Twenty-five (8%) Guaymi residing in Changuinola and 7 (2.1%) from Canquintu were confirmed seropositive. In Changuinola, antibody was virtually limited to residents greater than or equal to 15 years of age (24 [16%] of 153) and rates were slightly higher in males than in females; in Canquintu, antibody rates did not increase significantly with age and appeared higher in females than in males. In Changuinola, there was no evidence for household clustering of infection. In contrast, HTLV antibody among Canquintu residents clustered significantly by household. HTLV-associated neurologic disease was not detected in either population. The atypical seroepidemiology observed in both locations might be explained if the virus endemic to the Guaymi differed from HTLV-I previously described in the Caribbean basin and Japan.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2240369     DOI: 10.4269/ajtmh.1990.43.410

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  7 in total

1.  Complete nucleotide sequence of an Amerindian human T-cell lymphotropic virus type II (HTLV-II) isolate: identification of a variant HTLV-II subtype b from a Guaymi Indian.

Authors:  D Pardi; W M Switzer; K G Hadlock; J E Kaplan; R B Lal; T M Folks
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

Review 2.  Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety.

Authors:  E L Murphy
Journal:  Transfus Clin Biol       Date:  2016-01-05       Impact factor: 1.406

3.  Prevalence of HTLV types I and II among drug users in King County, Washington.

Authors:  H Thiede; N V Harris; J P McGough; B Roberts; R F Khabbaz; J E Kaplan
Journal:  West J Med       Date:  1994-06

4.  Virologic and genetic studies relate Amerind origins to the indigenous people of the Mongolia/Manchuria/southeastern Siberia region.

Authors:  J V Neel; R J Biggar; R I Sukernik
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

Review 5.  Origin and prevalence of human T-lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2) among indigenous populations in the Americas.

Authors:  Arthur Paiva; Jorge Casseb
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Jan-Feb       Impact factor: 1.846

6.  Low prevalence of HTLV1/2 infection in a population of immigrants living in southern Italy.

Authors:  Loredana Alessio; Carmine Minichini; Mario Starace; Laura Occhiello; Mara Caroprese; Giovanni Di Caprio; Caterina Sagnelli; Luciano Gualdieri; Mariantonietta Pisaturo; Lorenzo Onorato; Gaetano Scotto; Margherita Macera; Stefania De Pascalis; Evangelista Sagnelli; Nicola Coppola
Journal:  PLoS Negl Trop Dis       Date:  2018-06-25

7.  Frequency of adult T-cell leukaemia/lymphoma and HTLV-I in Ibadan, Nigeria.

Authors:  C K Williams; S S Alexander; A Bodner; A Levine; C Saxinger; R C Gallo; W A Blattner
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.